Skip to main content
SpringerLink
Log in

Antineoplastics

Myelotoxicity, acquired drug resistance and lack of efficacy: 4 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Orlandi A, et al. Poor efficacy of palbociclib in second-line treatment of metastatic lobular breast cancer in a case series: Use before or never more?. Breast Journal 26: 1458-1460, No. 7, Jul 2020. Available from: URL: http://doi.org/10.1111/tbj.13740

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antineoplastics. Reactions Weekly 1818, 40 (2020). https://doi.org/10.1007/s40278-020-82320-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-82320-7

Search

Navigation